Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03780777 · ClinicalTrials.gov registry record · NA

Removing Home Hazards for Older Adults in Affordable Housing

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
524
Enrollment target

NCT03780777: Completed NA study, sponsored by Washington University School of Medicine.

NCT03780777 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 524 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03780777, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
524 participants
Enrollment target

Study Summary

The investigators will conduct a hybrid effectiveness/implementation trial to simultaneously establish the effectiveness of home hazard removal in affordable housing in order to reduce falls, and conduct a process evaluation of how the intervention works in the context of low-income senior apartments.

Primary Outcome

Participation measured by percentage of eligible building residents enrolled

Interventions

  • BEHAVIORAL Home Hazard Removal

Trial Details

FieldValue
Enrollment Target 524 participants
Start Date 2019-04-15
Est. Completion 2021-06-09
Phase NA

What the finished NCT03780777 record still lists

NCT03780777 is an interventional study that assigns participants to a tested intervention. The registered 524 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).

The record links to 0 conditions, and to 1 intervention - of which Home Hazard Removal is the first listed.

NCT03780777 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03780777 about?

NCT03780777 is a clinical study titled "Removing Home Hazards for Older Adults in Affordable Housing". The investigators will conduct a hybrid effectiveness/implementation trial to simultaneously establish the effectiveness of home hazard removal in affordable housing in order to reduce falls, and conduct a process evaluation of how the intervention works in the context of low-income senior apartment...

What is the current status of trial NCT03780777?

This trial is currently completed. It is a NA study. The enrollment target is 524 participants. The study started on 2019-04-15. Estimated completion is 2021-06-09.

What interventions are being tested in trial NCT03780777?

The interventions under investigation include: Home Hazard Removal (BEHAVIORAL).

Who is sponsoring clinical trial NCT03780777?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03780777's enrollment target sits among peer trials

524 189th of 2000 higher than 1,812 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04580134 · 524 participants · Phase 4

    CLOZAPINE Response in Biotype-1

  • NCT07158814 · 524 participants · Phase 4

    Safety of RSV Preventive Monoclonal Antibody

  • NCT04769492 · 525 participants · NA

    #ChopViolence/#ChopHIV

  • NCT05260047 · 525 participants · NA

    Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03780777, the US trial registry maintained by the National Library of Medicine. NCT03780777 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.